MYH7B and hearing loss disorder: Notably, glutamine repeats contribute to protein aggregates that characterize many neurodegenerative diseases (58), presenting a reasonable hypothesis for the molecular pathogenicity of the MYH7b R1651Q mutation in hearing loss.